We report an HPLC assay for melatonin that incorporates automated injection, methanol/water mobile phase, and fluorescence detection. Plasma samples were extracted by solid and liquid phases. Recovery was >70% for 1-10 mL of plasma extracted, -40 pg-250 ng of melatonin. Samples were dried and reconstituted in 100 mL/L methanol. Injections were 25 pi. or 150 4, depending on sample concentration, and the melatonin peak was eluted in 380 mL/L methanol. The detection limit of the assay was 6 pg on the column, allowing a practical sensitivity in plasma of 11 pmol/L for 8-mL samples and 34 pmol/L for 2-mL samples. More than 100 plasma samples from volunteers and patients were assayed and the results compared with an established RIA. The mean daytime concentration of melatonin was 20.7 pmol/L (SEM = 1.2) and 18.5 pmol/L (SEM = 1.6) for HPLC and AlA, respectively, and the mean nighthme concentration was 82.4 pmol/L (SEM = 6.5) and 82.2 (SEM = 7.3), respectively. aration is time-consuming, and the assay is labor-intensive. Hence its use as a routine assay is impractical.
Melatonin, the principal hormone of the pineal gland, mediates those physiological and endocrinological processes that are controlled by the duration of light and darkness, particularly reproduction (1) (2) (3) . In humans, melatornn can also influence reproductive mechanisms (4), and there is now a melatonin-based oral contraceptive (5) . The use of RIA for plasma and serum estimations of melatonin is well established and there are commercially available kits. The first assays were developed by Arendt et al. (6) and Roliag and Niawender (7) , and reviews of the development of RIA systems for melatonin can be found in Rollag (8) and Arendt (9) . New RIA systems are being developed for specific research purposes with applications in humans and other mammals (10-13), birds (14-17), and fish (18) . A new RIA system should be validated with reference to an alternative methodology such as gas chromatographymass spectrometry (GC-MS) (19, 20) or by parallel studies against a standard (17,18,21).
An RIA has also been compared with an immunohistochemical assay of melatonin (22) aration is time-consuming, and the assay is labor-intensive. Hence its use as a routine assay is impractical.
HPLC has been used to validate the specificity of an RIA (12, 17, (25) (26) (27) in which the assayable material is shown to elute at the same retention time as standard melatonin. However, this is a qualitative rather than a quantitative validation. HPLC has been used quantitatively to assay melatonin as a synthetic standard or in tissue extracts, particularly of the pineal gland (28) (29) (30) (31) (32) (33) (34) (35) (36) . In these cases, melatonin is one of several indoles being measured and the methods of detection are either electrochemical or fluorescence-based. There are only three reports in which melatonin has been assayed in plasma with HPLC (37-39) and in these studies an electrochemical detector was used. We report the application of an HPLC assay for melatonin in plasma using a fluorescence detector; we eYamine the potential of this assay as a method for validating RIA or as a routine method of measurement in its own right. Pak cartridges, washed with water, washed with methanol at 100 mJ.lI., then at 600 milL, and then at 1000 milL. As shown in Figure 1 , 94% of the recovered counts of melatonin was eluted in the 600 mL/L methanol fractions (91% in the first 2 mL). Therefore, for all experiments, the following solid-phase extraction protocol was used: After the sample was loaded on the cartridge, it was washed with 2 mL of water followed by 2 mL of 100 milL methanol and eluted in 2 mL of 600 milL methanol; then the eluate was dried by centrifugation under reduced pressure.
Materials and Methods

Materials
Chemicals.
Melatonin
Recovery. With the protocol described above, we determined the variation in recovery of melatonin from 1 mL of plasma by using different concentrations of melatonin.
In the first experiment, 1-mL plasma samples containing 15 nCi of tritiated melatonin were extracted; the recovery of melatonin was 81% (range = 78-82%, n = 5). In the second experiment, 1-mL plasma samples containing 15 Five-or 10-mL plasma samples containing 15 nCi/mL tritiated melatonm were extracted. The recoveries of melatonin were 79% (5 mL, range = 77-81%, n = 4) and 81% (10 mL, range = 79-82%, n = 5).
Uquid-Phase Extraction
For all experiments in which liquid-phase extraction followed solid-phase extraction, the eluate was dried, reconstituted in 2 mL of water, and vortex-mixed with 2 mL of hexane for 30 S. The water phase was frozen in -100 niL of solid CO2Jacetone, and the hexane phase was decanted; the water phase was then vortex-mixed The recovery of melatonin in 2-mL samples of plsimla after solid-and liquid-phase extraction was calculated with the HPLC assay described below. For 25-150 ng/L, the recovery was 70%. HPLC assay of melatonin. The assay parameters are illustrated in Figure 2 . For the first 5 miii, the mobile phase was maintained at 300 milL methanol to allow the elution of polar plaRnln products. From 5 to 10 miii, the concentration of the mobile phase was increased exponentially to 380 milL methanol, where it remained for a further 10 miii, during which time the melatonun peak eluted. After 20 miii, the methanol concentration was increased to 820 mi.IL until 35 mm, allowing complete removal of late-elutung nonpolar plasma products.
From 35 to 40 mm, the column was brought back to starting conditions and allowed to equilibrate for 8 miii before the next injection. The flow rate of the mobile phase was 0.5 milmin at all stages except for the period during which the late-eluting peaks were washed off the column; it was then increased to 1.0 milmin. The application of this procedure is illustrated in Figure 3. A 5-mL plasma sample (taken from a normal adult volunteer during the daytime) was extracted by solid and liquid phases. The dried eluate was reconstituted with 200 L of 100 milL methanol, from which 150 pL was injected onto the column. All mnjor polar plasma products pass through the column in the first 10 miii, and the late-eluting products between 20 and 25 miii (Figure 3a) . Although barely visible in the complete chromatogram, the endogenous melatonin peak can be seen in the expanded 1-min chromatogram at the expected retention time for melatonun (13.9 miii) ( Figure  3b ). This can be compared with a 5-mL sample, from the same volunteer, to which 50 ng/L melatonin was added before and extracted and run in the same way. Here the melatonin peak is visible at 13.9 mm in the complete chromatogram ( Figure 3c ) and where the size of the melatonin peak has substantially increased in the axpanded chromatogram (Figure 3d ).
Assay variability.
The day-to-day variability 5.86-pg on-column standard profile. Hence we define the sensitivity of the assay as being -6 pg on the column.
Quality controls. Samples (2 mL) of the quality controls (n = 20 for each quality control) were extracted on solid and liquid phases. The samples were reconstituted in 200 L of 100 milL methanol. Aliquots (150 L) were injected onto the column in an assay that included standards in 100 milL methanol and 100 milL methanol blanks. The results are shown in Table 1 , which shows (a) that the HPLC assay value correlated with the nominal concentration of the quality controls and with the value calculated from the RIA, and (b) that the plasma blanks were below the limits of detection.
Volunteer and patients' samples. We assayed 119 dayand nighttime samples from volunteers of all ages by HPLC. For the HPLC assay, 2-mL samples were extracted and the detection limit for this volume was -34 pmolIL. The detection limit for the RIA was These samples were also assayed by RIA. For children, the day-and nighttime ranges obtained were 22- The results from all samples assayed are plotted in (r = 0.954; P <0.0001). The mean of all samples by HPLC is 42.7 ± 3.6 pmol/L, comparedwiththemeanRlAresultsof37.5 ± 4.1.
Discussion
Sagara et al. (38) used HPLC to measure melatonin in serum. In their study, 2-mL serum samples were extracted into a large volume of chloroform (12 mL), washed and dried several times, and two-thirds of the sample was injected onto a column and measured by electrochemical detection. The detection limit of the system was 15 pg on the column and the practical limits of the assay for serum were -82 pmol/L. Sagara et al. used the system to measure melatonin in healthy normal volunteers; however, they did not compare their results with an alternative methodology. Raynaud and Pevet (37) also used an HPLC-electrochemical system to measure melatonin in plasma. In their study, hamster plasma samples (volume unknown) were extracted into five volumes of dichloromethane, and four-fifths of the sample was injected onto the column. The detection limit of the system was 4 pg on the column and the practical limits of the assay were 43 pmol/L. Though the authors did not report what samples they measured, they stated that the HPLC results accorded well with results previously obtained with RIA. Vieira et aL (39) have similnrly used HPLC with electrochemical detection to measure melatonin both in rat pineals and in hnmnn plasma. They extracted the plasma samples (2 mL) into dichloromethane and reconstituted the organic phase in water and filtered by centrifugation before four-fifths of the sample was injected onto the column. The detection limit of the assay was 1 pg on the column; practical limits of the assay were -5 pmol/L. The samples assayed showed a clear diurnal variation, and, although these results were not compared with an alternative methodology, the authors stated that the results obtained by HPLC were in line with those previously reported.
In our study we attempted to make the HPLC assay of melatonin in plasma a practical procedure. We introduced a simple one-stage solid-phase extraction that is suitable for all samples cont.nining >1 g'L, i.e., for most pharmacokinetic studies. The extraction step is necessary to ensure that the guard column is itself protected from particulate matter, thereby allowing multiple injections (large assays) to be performed day and night with an automated sample injector without deterioration of the assay. However, it is advisable, even with an extraction step, to replace the guard column on a regular basis.
To measure endogenous concentrations of melatornn, where sensitivity <1 ,ugfL is required, we introduced a second liquid-phase extraction to reduce the level of baseline noise and to permit a greater volume of plasma to be loaded onto the column. With this method, oncolumn sensitivity is 6 pg, >4 mL of sample can be extracted, 70% of the sample is recovered from the extraction, 75% of the sample is loaded on the column, and the practical limit of the assay for plasma is -11 pmol/L (3 ngfL) with 8-mL samples and 34 pmol/L (8 ng/L) with 2-mL samples.
The HPLC methodology we developed is robust. The mobile phase is simple (methanol and water), the column allows comparatively rapid separation and regeneration, and the detector is reliable. Compared with RIA, the principal disadvantage of the system is that a large volume of sample is required when low concentrations are being measured. The principal advantages are that the system has a wide dynamic range and is a comparatively simple nonbiological assay for melatonin.
